Suramin Inhibits Not Only Tumor Growth and Metastasis but Also Angiogenesis in Experimental Pancreatic Cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Surgery
Link
http://link.springer.com/content/pdf/10.1007/s11605-006-0081-z.pdf
Reference30 articles.
1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1997. CA Cancer J Clin 1997;47(1):5–27.
2. Kabbinavar F, Hurwitz HI, Fehrenbacher L, Meropol NJ, Novotny WF, Lieberman G, et al. Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer. J Clin Oncol 2003;21(1):60–65.
3. Fiedler W, Mesters R, Tinnefeld H, Loges S, Staib P, Duhrsen U, et al. A phase 2 clinical study of SU5416 in patients with refractory acute myeloid leukemia. Blood 2003;102(8):2763–2767.
4. Hawking F. Suramin: with special reference to onchocerciasis. Adv Pharmacol Chemother 1978;15:289–322.
5. Coffey RJ Jr, Leof EB, Shipley GD, Moses HL. Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells. J Cell Physiol 1987;132(1):143–148.
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Bioelectric pharmacology of cancer: A systematic review of ion channel drugs affecting the cancer phenotype;Progress in Biophysics and Molecular Biology;2024-09
2. Sphingolipid Metabolism in Cancer: Potential Therapeutic Target;Handbook of Cancer and Immunology;2023
3. K562 KRONİK MİYELOİD LÖSEMİ HÜCRE HATTINDA SIRT5 MODÜLATÖRLERİNİN SIRT5 VE SİTOKROM C PROTEİN EKSPRESYONLARI ÜZERİNE ETKİLERİNİN ARAŞTIRILMASI;Ankara Universitesi Eczacilik Fakultesi Dergisi;2022-09-27
4. P2Y Purinergic Receptor Signaling in Oral Squamous Cell Carcinoma Cell Lines and Its Role in Proliferation and Cisplatin-Mediated Apoptosis;Sains Malaysiana;2022-01-31
5. Old Polyanionic Drug Suramin Suppresses Detrimental Cytotoxicity of the Host Defense Peptide LL-37;ACS Pharmacology & Translational Science;2020-12-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3